Results 121 to 130 of about 30,378 (204)

Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]

BMC Pharmacol Toxicol
Wang L, Jin G, Wang W, Zhao J, Chen F, Li X, Jiang Y, Zhang Z, Li Q.   +8 more
europepmc   +1 more source

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. [PDF]

Support Care Cancer
Chow R, Basu A, Kaur J, Hui D, Im J, Prsic E, Boldt G, Lock M, Eng L, Ng TL, Zimmermann C, Scotte F.   +11 more
europepmc   +1 more source

Effective Use of Olanzapine for Chemotherapy-Induced Nausea and Vomiting in a Patient Receiving Dose-Adjusted Rituximab, Etoposide, Prednisone, Vincristine (Oncovin®), Cyclophosphamide, and Doxorubicin (R-EPOCH): A Case Report. [PDF]

Cureus
Shimada H, Ohgami M, Kurokawa Y, Tachihara S, Sugaya A.   +4 more
europepmc   +1 more source

Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Jin K, Lin X, Xia X, Ye H, Yang D, Fan Y, Sun Q, Wang R.   +7 more
europepmc   +1 more source

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Sarma I, Buragohain S, Lahon J, Banerjee P, Kumar S, Chetia R, Baishya P, Saikia D.   +7 more
europepmc   +1 more source

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]

Future Oncol
Navari RM, Tyler T, Inui N, Iihara H, Bonizzoni E, Park YH, Rugo HS, Roeland EJ.   +7 more
europepmc   +1 more source

High Outcome-Reporting Bias in Randomized-Controlled Trials of Acupuncture for Cancer Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Epidemiological Study. [PDF]

Curr Oncol
Penati R, Vecchio R, Gatto R, Odone A, Deandrea S.   +4 more
europepmc   +1 more source

Evaluation of chemotherapy-induced nausea and vomiting in low, moderate, and highly emetogenic schemes between sexes. [PDF]

Support Care Cancer
Albanell-Fernández M, Rodríguez Mues MC, Figueras C, Altamirano M, Monge-Escartín I, Riu-Viladoms G, Carcelero San Martín E, Corominas Bosch ML, Gaba García L.   +8 more
europepmc   +1 more source

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis. [PDF]

Front Pharmacol
Ning C, Yan Y, Wang Y, Li R, Liu W, Qiu L, Sun L, Yang Y.   +7 more
europepmc   +1 more source

STOP-CINV Study: Safety and Efficacy of IV Akynzeo® (Fosnetupitant 235 mg and Palonosetron 0.25 mg) for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Indian Patients. [PDF]

Cureus
Shukla P, Valame S, Nanda S, Shakya NK, Verma AK, Hanji A, Pednekar A, Bhagat S, Patil S, Petare AU, Bhushan S, Barkate H.   +11 more
europepmc   +1 more source